(WASHINGTON, DC) Today, the American Pharmacists Association (APhA) announced that Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, has been named the 15th Chief Executive Officer and Executive Vice President of APhA.
Categories: Press Releases
Tags: Press Releases, press release
(Washington, DC) American Pharmacists Association (APhA) and its House of Delegates, the premier policy-making body for the pharmacy profession, considered and adopted new policies on pressing issues during APhA’s annual meeting on March 24 –27, 2023, in Phoenix.
The American Pharmacists Association (APhA) commends the U.S. Department of Health and Human Services (HHS) for announcing that they will ensure that patients can continue to get COVID-19–related care from their pharmacists. APhA is grateful that HHS listened to the concerns of APhA and others in the pharmacy community in expressing a need for HHS to clarify the role of pharmacists and pharmacy teams when the public health emergency expires on May 11, 2023.
The American Pharmacists Association released the following statement in response to the decision in the Alliance for Hippocratic Medicine v U.S. Food and Drug Administration lawsuit file in the US District Court for the Northern District of Texas, regarding FDA approval of mifepristone.
H.R. 1770 Would Provide Payment for Pharmacist Services for COVID-19, Flu, Strep & RSV Under Medicare Part B and Ensure Pharmacists Can Continue to Protect Vulnerable Senior Communities